Filing Details

Accession Number:
0001127602-20-029815
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-23 13:54:55
Reporting Period:
2020-11-20
Accepted Time:
2020-11-23 13:54:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
816956 Conmed Corp CNMD Electromedical & Electrotherapeutic Apparatus (3845) 160977505
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1635424 M Terence Berge C/O Conmed Corporation
525 French Road
Utica NY 13502
Vp-Corporate Controller No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-11-20 5,000 $101.54 10,912 No 4 S Direct
Common Stock Acquisiton 2020-11-20 9,040 $39.87 19,952 No 4 M Direct
Common Stock Disposition 2020-11-20 9,040 $101.51 10,912 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options To Purchase Common Stock Disposition 2020-11-20 9,040 $0.00 9,040 $39.87
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,860 2026-03-01 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.38 to $101.85. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.38 to $101.76. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  3. The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period